For many years, bone marrow was used as the mainly source of cells. Cells collected from stimulated peripheral blood has been at increased use, initially for autologous transplantation and now for allogeneic transplantation. Another source of CD34+ cells is cord blood, with high replicative capacity...
samples with the highest content of CD34+ cells, while the three assays provide equivalent results for values that are close to clinically relevant thresholds (20 × 103 CD34+ cells/ml in peripheral blood to start apheresis, and accumulated number above 3 × 106 CD34+ cells/kg to stop ...
Miclea, J., Chomienne, C. Flow cytometry comparison of CD34+subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF.Bone Marrow Transplant24, 441–442 (1999). https://doi.org/10.1038/sj.bmt.1701911 ...
Bone Marrow TransplantationDitschkowski M,,Trenschel R,Kummer G,et al.Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria.Bone Marrow Transplantation. 2003Ditschkowski M, Trenschel R, Kummer G, Elmaagacil AH, Beelen DW. Allogeneic...
Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF. Johnsen HE (1998) Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated G-CSF......
administered G-CSF at a dose of 3μg/kg, the number of PB CD34+cells should be harvested as much as possible to perform allogeneic peripheral blood stem cell transplantation (PBSCT).
-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation Bone Marrow TransplantationUrbano-Ispizua, A.Brunet, S.Solano, C.Moraleda, J. M.Rovira, M.Zuazu, J.de la Rubia, J.Bargay, J....
The objectives of this phase I study were to assess the feasibility of using cryopreserved peripheral-blood progenitor cells (PBPC) for large-scale CD34 se... MJ Alcorn,TL Holyoake,L Richmond,... - 《Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology》...
Bone Marrow Transplantation volume 25, pages 1223–1228 (2000)Cite this article 350 Accesses Metrics details Abstract GVHD is a significant cause of morbidity and mortality following allogeneic peripheral blood stem cell transplantation (AlloPBSC). CD34+ cell selection could reduce GVHD by negative ...
CD34 selection of peripheral hematopoietic blood stem cell products has been applied to reduce the risk of relapse after an autologous transplantation. How... E.,Carreras,and,... - 《Biology of Blood & Marrow Transplantation》 被引量: 323发表: 2003年 CD34+-selected autologous peripheral blood ...